MANGOCEUTICALS, INC.(MGRX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

MANGOCEUTICALS, INC. (MGRX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MGRX at 9.6/100 on a 32-signal composite quality model, placing it at rank #2,915 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), MANGOCEUTICALS, INC. reports quarterly revenue of $68.8K, net income of $-1.3M. Top institutional holders of MGRX by reported 13-F value include CITADEL ADVISORS, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. MGRX trades on the Nasdaq exchange and files with the SEC under CIK 1938046. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MGRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MANGOCEUTICALS, INC. directly from SEC EDGAR.